These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 37161947

  • 1. Predictors of falls in Parkinson's disease, progressive supranuclear palsy, and multiple system atrophy: a retrospective study.
    Altmann CF, Koschel J, Jost WH.
    Neurol Neurochir Pol; 2023; 57(3):297-304. PubMed ID: 37161947
    [Abstract] [Full Text] [Related]

  • 2. Comparison of autonomic dysfunction in patients with Parkinson's Disease, progressive supranuclear palsy, and multiple system atrophy.
    Malkiewicz JJ, Siuda J.
    Neurol Neurochir Pol; 2024; 58(2):193-202. PubMed ID: 38148738
    [Abstract] [Full Text] [Related]

  • 3. Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy.
    Fiorenzato E, Weis L, Falup-Pecurariu C, Diaconu S, Siri C, Reali E, Pezzoli G, Bisiacchi P, Antonini A, Biundo R.
    J Neural Transm (Vienna); 2016 Dec; 123(12):1435-1442. PubMed ID: 27334897
    [Abstract] [Full Text] [Related]

  • 4. Clinical outcomes of progressive supranuclear palsy and multiple system atrophy.
    O'Sullivan SS, Massey LA, Williams DR, Silveira-Moriyama L, Kempster PA, Holton JL, Revesz T, Lees AJ.
    Brain; 2008 May; 131(Pt 5):1362-72. PubMed ID: 18385183
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Identification of multiple system atrophy mimicking Parkinson's disease or progressive supranuclear palsy.
    Miki Y, Tsushima E, Foti SC, Strand KM, Asi YT, Yamamoto AK, Bettencourt C, Oliveira MCB, De Pablo-Fernández E, Jaunmuktane Z, Lees AJ, Wakabayashi K, Warner TT, Quinn N, Holton JL, Ling H.
    Brain; 2021 May 07; 144(4):1138-1151. PubMed ID: 33822892
    [Abstract] [Full Text] [Related]

  • 9. Speech disorders reflect differing pathophysiology in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
    Rusz J, Bonnet C, Klempíř J, Tykalová T, Baborová E, Novotný M, Rulseh A, Růžička E.
    J Neurol; 2015 May 07; 262(4):992-1001. PubMed ID: 25683763
    [Abstract] [Full Text] [Related]

  • 10. Characteristics and progression of cognitive deficits in progressive supranuclear palsy vs. multiple system atrophy and Parkinson's disease.
    Fiorenzato E, Antonini A, Camparini V, Weis L, Semenza C, Biundo R.
    J Neural Transm (Vienna); 2019 Nov 07; 126(11):1437-1445. PubMed ID: 31432258
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Predictors of survival in progressive supranuclear palsy and multiple system atrophy: a systematic review and meta-analysis.
    Glasmacher SA, Leigh PN, Saha RA.
    J Neurol Neurosurg Psychiatry; 2017 May 07; 88(5):402-411. PubMed ID: 28250027
    [Abstract] [Full Text] [Related]

  • 13. Dyskinesia in multiple system atrophy and progressive supranuclear palsy.
    Jost WH, Lingor P, Tönges L, Schwarz J, Buhmann C, Kassubek J, Schrag A.
    J Neural Transm (Vienna); 2019 Jul 07; 126(7):925-932. PubMed ID: 31087195
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Clinical outcomes and cognitive impairments between progressive supranuclear palsy and multiple system atrophy.
    Jia P, Zhang J, Han J, Ji Y.
    Brain Behav; 2022 Dec 07; 12(12):e2827. PubMed ID: 36409061
    [Abstract] [Full Text] [Related]

  • 16. Improving diagnostic accuracy of multiple system atrophy: a clinicopathological study.
    Miki Y, Foti SC, Asi YT, Tsushima E, Quinn N, Ling H, Holton JL.
    Brain; 2019 Sep 01; 142(9):2813-2827. PubMed ID: 31289815
    [Abstract] [Full Text] [Related]

  • 17. The odor stick identification test for Japanese differentiates Parkinson's disease from multiple system atrophy and progressive supra nuclear palsy.
    Suzuki M, Hashimoto M, Yoshioka M, Murakami M, Kawasaki K, Urashima M.
    BMC Neurol; 2011 Dec 22; 11():157. PubMed ID: 22192419
    [Abstract] [Full Text] [Related]

  • 18. Significance of apparent diffusion coefficient measurement for the differential diagnosis of multiple system atrophy, progressive supranuclear palsy, and Parkinson's disease: evaluation by 3.0-T MR imaging.
    Tsukamoto K, Matsusue E, Kanasaki Y, Kakite S, Fujii S, Kaminou T, Ogawa T.
    Neuroradiology; 2012 Sep 22; 54(9):947-55. PubMed ID: 22274571
    [Abstract] [Full Text] [Related]

  • 19. Patterns of Eye Movement Impairment Correlate with Regional Brain Atrophy in Neurodegenerative Parkinsonism.
    Vintonyak O, Gorges M, Müller HP, Pinkhardt EH, Ludolph AC, Huppertz HJ, Kassubek J.
    Neurodegener Dis; 2017 Sep 22; 17(4-5):117-126. PubMed ID: 28268209
    [Abstract] [Full Text] [Related]

  • 20. Comprehensive autonomic assessment does not differentiate between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
    Reimann M, Schmidt C, Herting B, Prieur S, Junghanns S, Schweitzer K, Globas C, Schoels L, Reichmann H, Berg D, Ziemssen T.
    J Neural Transm (Vienna); 2010 Jan 22; 117(1):69-76. PubMed ID: 19763772
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.